Canderin 8mg tablets

Dexa Medica

Ingredients in every tablet

Candesartan 8 mg

Each package contains

3 blisters of 10 tablets

Other details

Dosage form:Tablet; plain
Flavour: None

W.H.O. classification

ATC Level 1: C - Cardiovascular system
ATC Level 2: C09 - Agents Acting on the Renin-Angiotensin System
ATC Level 3: C09C - Angiotensin II Receptor Blockers (Arbs); Plain



NOT SAFEThis item is not safe for use during pregnancy.


NOT SAFEThis item is not safe for use during lactation.


CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.


CAUTIONThis item may not be safe for use while operating heavy machinery. Use with caution.

Available in


Dosage information

The safety and efficacy of candesartan have not been established in children and adolescents (under 18 years).

Dosage in hypertension:
The initial dose is 4 mg once daily. The dose should be adjusted according to response, with a maximum dose of 16 mg daily. The maximum effect is achieved within about 4 weeks after initiating therapy.

Use in impaired renal function
No initial dosage adjustment is necessary in mild renal impairment. A lower initial dose of 2 mg once daily is suggested for patients with moderate and severe renal impairment. The dose may be adjusted according to response.

Use in impaired hepatic function
An initial dose of 2 mg once daily is recommended in patients with mild to moderate hepatic impairment. The dose may be adjusted according to response. There is no experience in patients with severe hepatic impairment.

Dosage in heart failure:
The usual recommended initial dose is 4 mg once daily. Up-titration to the target dose of 32 mg once daily or the highest tolerated dose is done by doubling the dose at intervals of at least 2 weeks.

No initial dosage adjustment is necessary in elderly patients.

Candesartan should be taken once daily with or without food. Candesartan can be administered with other antihipertensive drugs


Treatment of hypertension.
Treatment of patients with heart failure and impaired left ventricle systolic function (left ventricular ejection fraction ≤ 40%) when ACE-inhibitors are not tolerated.


The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for informational purposes only. This tool may not cover all possible drug interactions or all warnings or alerts. Please check with a physician if you have health questions or concerns about interactions or go to the appropriate government authority for a comprehensive list of medical warnings. Although we attempt to provide accurate and up-to-date information, no guarantee is made to that effect.

All of the content present on this website, including written text, photographs, videos, graphics, and other resources we might include (these will fall under the collective term of “website”), is meant to educate and should not be perceived as a substitution for professional medical advice, diagnosis or treatment. You should not resort to the website information to arrive at a diagnosis or treatment solution for your health problems or various medical conditions. It does not replace medical care, provided by a medical specialist. In the situation, you have specific symptoms and you might suspect that you are suffering from a medical problem, it is for the best to consult your physician.